187 related articles for article (PubMed ID: 24248418)
21. Possible proteomic biomarkers for the detection of pancreatic cancer in oral fluids.
Deutsch O; Haviv Y; Krief G; Keshet N; Westreich R; Stemmer SM; Zaks B; Navat SP; Yanko R; Lahav O; Aframian DJ; Palmon A
Sci Rep; 2020 Dec; 10(1):21995. PubMed ID: 33319845
[TBL] [Abstract][Full Text] [Related]
22. Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach.
Park J; Lee E; Park KJ; Park HD; Kim JW; Woo HI; Lee KH; Lee KT; Lee JK; Park JO; Park YS; Heo JS; Choi SH; Choi DW; Jang KT; Lee SY
Oncotarget; 2017 Jun; 8(26):42761-42771. PubMed ID: 28514751
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer.
Ou ZL; Luo Z; Lu YB
World J Gastroenterol; 2019 Dec; 25(46):6728-6742. PubMed ID: 31857775
[TBL] [Abstract][Full Text] [Related]
24. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach.
Grønborg M; Kristiansen TZ; Iwahori A; Chang R; Reddy R; Sato N; Molina H; Jensen ON; Hruban RH; Goggins MG; Maitra A; Pandey A
Mol Cell Proteomics; 2006 Jan; 5(1):157-71. PubMed ID: 16215274
[TBL] [Abstract][Full Text] [Related]
25. Proteome analysis of human pancreatic cancer cell lines with highly liver metastatic potential by antibody microarray.
Shi W; Meng Z; Chen Z; Luo J; Liu L
Mol Cell Biochem; 2011 Jan; 347(1-2):117-25. PubMed ID: 20960035
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the autophagy gene expression profile of pancreatic cancer based on autophagy-related protein microtubule-associated protein 1A/1B-light chain 3.
Yang YH; Zhang YX; Gui Y; Liu JB; Sun JJ; Fan H
World J Gastroenterol; 2019 May; 25(17):2086-2098. PubMed ID: 31114135
[TBL] [Abstract][Full Text] [Related]
27. Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer.
Lukosiute-Urboniene A; Jasukaitiene A; Silkuniene G; Barauskas V; Gulbinas A; Dambrauskas Z
World J Gastroenterol; 2019 Jan; 25(2):205-219. PubMed ID: 30670910
[TBL] [Abstract][Full Text] [Related]
28. New era of integrated cancer biomarker discovery using reverse-phase protein arrays.
Nishizuka SS; Mills GB
Drug Metab Pharmacokinet; 2016 Feb; 31(1):35-45. PubMed ID: 26822993
[TBL] [Abstract][Full Text] [Related]
29. Protein deep sequencing applied to biobank samples from patients with pancreatic cancer.
Ansari D; Andersson R; Bauden MP; Andersson B; Connolly JB; Welinder C; Sasor A; Marko-Varga G
J Cancer Res Clin Oncol; 2015 Feb; 141(2):369-80. PubMed ID: 25216700
[TBL] [Abstract][Full Text] [Related]
30. Discovery of biomarkers for gastric cancer: a proteomics approach.
Lin LL; Huang HC; Juan HF
J Proteomics; 2012 Jun; 75(11):3081-97. PubMed ID: 22498886
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells.
Sclabas GM; Fujioka S; Schmidt C; Li Z; Frederick WA; Yang W; Yokoi K; Evans DB; Abbruzzese JL; Hess KR; Zhang W; Fidler IJ; Chiao PJ
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):440-9. PubMed ID: 15701826
[TBL] [Abstract][Full Text] [Related]
32. Signaling pathway profiling by reverse-phase protein array for personalized cancer medicine.
Masuda M; Yamada T
Biochim Biophys Acta; 2015 Jun; 1854(6):651-7. PubMed ID: 25448010
[TBL] [Abstract][Full Text] [Related]
33. Expression and prognostic significance of 14-3-3sigma and ERM family protein expression in periampullary neoplasms.
Hustinx SR; Fukushima N; Zahurak ML; Riall TS; Maitra A; Brosens L; Cameron JL; Yeo CJ; Offerhaus GJ; Hruban RH; Goggins M
Cancer Biol Ther; 2005 May; 4(5):596-601. PubMed ID: 15908786
[TBL] [Abstract][Full Text] [Related]
34. Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines.
Alhamdani MS; Youns M; Buchholz M; Gress TM; Beckers MC; Maréchal D; Bauer A; Schröder C; Hoheisel JD
J Proteomics; 2012 Jun; 75(12):3747-59. PubMed ID: 22579748
[TBL] [Abstract][Full Text] [Related]
35. Proteomics for discovery of candidate colorectal cancer biomarkers.
Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574
[TBL] [Abstract][Full Text] [Related]
36. Distinct Protein Expression Profiles of Solid-Pseudopapillary Neoplasms of the Pancreas.
Park M; Lim JS; Lee HJ; Na K; Lee MJ; Kang CM; Paik YK; Kim H
J Proteome Res; 2015 Aug; 14(8):3007-14. PubMed ID: 26148796
[TBL] [Abstract][Full Text] [Related]
37. Comparative proteomic analysis of differentially expressed proteins in human pancreatic cancer tissue.
Chen JH; Ni RZ; Xiao MB; Guo JG; Zhou JW
Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):193-200. PubMed ID: 19357035
[TBL] [Abstract][Full Text] [Related]
38. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
[TBL] [Abstract][Full Text] [Related]
39. Identification and validation of a prognostic proteomic signature for cervical cancer.
Rader JS; Pan A; Corbin B; Iden M; Lu Y; Vellano CP; Akbani R; Mills GB; Simpson P
Gynecol Oncol; 2019 Nov; 155(2):324-330. PubMed ID: 31477280
[TBL] [Abstract][Full Text] [Related]
40. Molecular beacon imaging of tumor marker gene expression in pancreatic cancer cells.
Yang L; Cao Z; Lin Y; Wood WC; Staley CA
Cancer Biol Ther; 2005 May; 4(5):561-70. PubMed ID: 15917666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
